Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Ruby Khatun Khatun
    Ruby Khatun Khatun
      • Home
      • Ruby Khatun Khatun

      Articles By : Ruby Khatun Khatun

      US House committee launches probe of Allergan patent deal

      US House committee launches probe of Allergan patent deal

      Ruby Khatun Khatun6 Oct 2017 9:00 AM IST
      NEW YORK: A U.S. House of Representatives committee launched a probe into drugmaker Allergan Plc's deal to transfer some of its patents to a Native...
      Eris Lifesciences acquires UTH Healthcare for Rs 12.85 crore

      Eris Lifesciences acquires UTH Healthcare for Rs 12.85 crore

      Ruby Khatun Khatun5 Oct 2017 2:39 PM IST
      New Delhi: Eris Lifesciences said it has acquired nutraceuticals maker UTH Healthcare for Rs 12.85 crore.UTH Healthcare is largely present in obesity,...
      Natco Pharma to invest Rs 100 crore in API facility in TN

      Natco Pharma to invest Rs 100 crore in API facility in TN

      Ruby Khatun Khatun5 Oct 2017 11:12 AM IST
      Chennai: Nacto pharma is planning to invest in its existing facility and expand its Active Pharmaceutical Ingredient (API) and intermediates...
      Fosun Pharma acquires 74 percent stake in Gland Pharma for 1.09 billion dollar

      Fosun Pharma acquires 74 percent stake in Gland Pharma for 1.09 billion dollar

      Ruby Khatun Khatun5 Oct 2017 10:53 AM IST
      New Delhi: Chinese drug firm Fosun Pharma has acquired approximately 74 percent in Hyderabad-based Gland Pharma at a valuation of not more than USD...
      Zydus gets USFDA nod to market anti-diuretic nasal spray

      Zydus gets USFDA nod to market anti-diuretic nasal spray

      Ruby Khatun Khatun5 Oct 2017 10:17 AM IST
      New Delhi: Drug firm Zydus Cadila said it has received final approval from the US health regulator to market anti-diuretic Desmopressin nasal spray...
      Police raid French HQ of pharma giant Merck

      Police raid French HQ of pharma giant Merck

      Ruby Khatun Khatun5 Oct 2017 9:49 AM IST
      Paris: Police on Tuesday raided the French headquarters of German pharmaceutical giant Merck, the maker of a thyroid drug at the center of a medical...
      Malaysian state keen to collaborate with India on biotech, ICT

      Malaysian state keen to collaborate with India on biotech, ICT

      Ruby Khatun Khatun5 Oct 2017 9:20 AM IST
      New Delhi: Malaysian state of Selangor has expressed interest in collaborating with India in the fields of biotechnology, ICT, life sciences,...
      Typhoid vaccine by Bharat Biotech shows efficacy

      Typhoid vaccine by Bharat Biotech shows efficacy

      Ruby Khatun Khatun4 Oct 2017 3:50 PM IST
      Hyderabad: Vaccine Innovator Bharat Biotech has announced that its next-generation typhoid vaccine, Typbar-TCV, has demonstrated its safety and...
      Natco pharma partner Mylan gets USFDA nod for multiple sclerosis injection

      Natco pharma partner Mylan gets USFDA nod for multiple sclerosis injection

      Ruby Khatun Khatun4 Oct 2017 10:55 AM IST
      New Delhi: The US Food and Drug Administration has granted approval to drug major Natco Pharma's marketing partner Mylan's Glatiramer Acetate...
      MedGenome Labs to raise another 10 million dollars in Series C round

      MedGenome Labs to raise another 10 million dollars in Series C round

      Ruby Khatun Khatun4 Oct 2017 10:47 AM IST
      Bhubaneshwar: Genomics research and diagnostics startup MedGenome Labs Tuesday said after successfully raising USD 30 million, it is raising another...
      FDA acts to encourage generic competition for complex drugs

      FDA acts to encourage generic competition for complex drugs

      Ruby Khatun Khatun4 Oct 2017 10:46 AM IST
      TRENTON, N.J.: The U.S. Food and Drug Administration (FDA) is opening a new front in its efforts to reduce high drug prices by encouraging the...
      Merck to stop development of hepatitis C treatments

      Merck to stop development of hepatitis C treatments

      Ruby Khatun Khatun4 Oct 2017 10:20 AM IST
      U.S. drugmaker Merck & Co said on Friday it would discontinue developing an experimental drug combination for chronic hepatitis C, as competition...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok